Identification of 15-hydroxy-11,12-epoxyeicosatrienoic acid as a vasoactive 15-lipoxygenase metabolite in rabbit aorta

1 Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin; 2 Department of Biochemistry, University of Texas Southwestern Medical School, Dallas, Texas; and 3 Department of Entomology and Cancer Research Center, University of California, Davis, California Submit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2008-03, Vol.294 (3), p.H1348-H1356
Hauptverfasser: Chawengsub, Yuttana, Aggarwal, Nitin T, Nithipatikom, Kasem, Gauthier, Kathryn M, Anjaiah, Siddam, Hammock, Bruce D, Falck, John R, Campbell, William B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1 Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin; 2 Department of Biochemistry, University of Texas Southwestern Medical School, Dallas, Texas; and 3 Department of Entomology and Cancer Research Center, University of California, Davis, California Submitted 12 November 2007 ; accepted in final form 11 January 2008 Arachidonic acid (AA) causes endothelium-dependent smooth muscle hyperpolarizations and relaxations that are mediated by a 15-lipoxygenase-I (15-LO-I) metabolite, 11,12,15-trihydroxyeicosatrienoic acid (11,12,15-THETA). We propose that AA is metabolized sequentially by 15-LO-I and hydroperoxide isomerase to an unidentified hydroxyepoxyeicosatrienoic acid (HEETA), which is hydrolyzed by a soluble epoxide hydrolase (sEH) to 11,12,15-THETA. After incubation of aorta with 14 C-labeled AA, metabolites were extracted and the HEETAs were resolved by performing HPLC. Mass spectrometric analyses identified 15-Hydroxy-11,12-epoxyeicosatrienoic acid (15-H-11,12-EETA). Incubation of aortic incubates with methanol and acetic acid trapped the acid-sensitive 15-H-11,12-EETA as methoxydihydroxyeicosatrienoic acids (MDHEs) (367 m / z , M-H). Pretreatment of the aortic tissue with the sEH inhibitor 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA; 10 –6 M) increased the formation of 15-H-11,12-EETA, measured as MDHEs. Thus 15-H-11,12-EETA is an acid- and sEH-sensitive precursor of 11,12,15-THETA. Aortic homogenates and endothelial cells contain a 57-kDa protein corresponding to the rabbit sEH. In preconstricted aortic rings, AA (10 –7 –10 –4 M) and acetylcholine (10 –9 –10 –6 M) caused concentration-related relaxations that were enhanced by pretreatment with AUDA. These enhanced relaxations were inhibited by increasing extracellular [K + ] from 4.8 to 20 mM. AA (3 x 10 –6 M) induced cell membrane hyperpolarization (from –31.0 ± 1 to –46.8 ± 2 mV) in aortic strips with an intact endothelium, which was enhanced by AUDA. These results indicate that 15-H-11,12-EETA is produced by the aorta, hydrolyzed by sEH to 11,12,15-THETA, and mediates relaxations by membrane hyperpolarization. 15-H-11,12-EETA represents an endothelium-derived hyperpolarizing factor. arachidonic acid; endothelial cells; endothelium-derived hyperpolarizing factor; 15-lipoxygenase Address for reprint requests and other correspondence: W. B. Campbell, Dept. of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwauke
ISSN:0363-6135
1522-1539
DOI:10.1152/ajpheart.01326.2007